Jichi Medical University, Center for Molecular Medicine, Nishimura lab

Jichi Medical University,
Center for Molecular Medicine,

Nishimura lab


ADDRESS:
3311-1 Yakushiji,
Shimotsuke-shi,
Tochigi,
Japan 329-0498 +81-285-44-2111


Please contact us for use of the image and video.

Publication

Home » Publication
2014

ENPP2 contributes to adipose Tissue expansion and insulin resistance in diet-induced obesity.

Nishimura S, Nagasaki M, Okudaira S, Aoki J, Ohmori T, Ohkawa R, Nakamura K, Igarashi K, Yamashita H, Eto K, Uno K, Hayashi N, Kadowaki T, Komuro I, Yatomi Y, Nagai R.

Diabetes. 2014; 63(12): 4154-64.

Paxillin is an intrinsic negative regulator of platelet activation in mice.

Sakata A, Ohmori T, Nishimura S, Suzuki H, Madoiwa S, Mimuro J, Kario K, Sakata Y.

Thromb J. 2014; 12(1): 1.

Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study.

Koyama K, Madoiwa S, Nunomiya S, Koinuma T, Wada M, Sakata AOhmori T, Mimuro J, Sakata Y.
Crit Care. 2014; 18(1): R13.

Expandable Megakaryocyte Cell Lines Enable Clinically Applicable Generation of Platelets from Human Induced Pluripotent Stem Cells.

Nakamura S, Takayama N, Hirata S, Seo H, Endo H, Ochi K, Fujita K, Koike T, Harimoto K, Dohda T, Watanabe A, Okita K, Takahasi N, Sawaguchi A, Yamanaka S, Nakauchi H, Nishimura S, Eto K. 

Cell Stem Cell. 2014; 14(4): 535-48.

Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis.

Tanaka M, Ikeda K, Suganami T, Komiya C, Ochi K, Shirakawa I, Hamaguchi M, Nishimura S, Manabe I, Matsuda T, Kimura K, Inoue H, Inagaki Y, Aoe S, Yamasaki S, Ogawa Y.

Nat Commun. 2014; 5: 4982.

Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.

Noda S, Asano Y, Nishimura S, Taniguchi T, Fujiu K, Manabe I, Nakamura K, Yamashita T, Saigusa R, Akamata K, Takahashi T, Ichimura Y, Toyama T, Tsuruta D, Trojanowska M, Nagai R, Sato S.
Nat Commun. 2014; 5: 5797.

Estrogen dependence of PDE5 inhibitor efficacy in female heart disease.

Sasaki H, Nagayama T, Blanton RM, Seo K, Zhang M, Zhu G, Lee DI, Bedja D, Hsu S, Tsukamoto O, Takashima S, Kitakaze M, Mendelsohn ME, Karas RH, Kass DA, Takimoto E.

J Clin Invest. 2014; 124(6): 2464-2471.

TUBB1 mutation disrupting microtubule assembly impairs proplatelet formation and results in congenital macrothrombocytopenia.

Kunishima S, Nishimura S, Suzuki H, Imaizumi M, Saito H.

Eur J Haematol. 2014; 92(4): 276-82.